KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Neogenomics (NEO) Tax Provisions (2016 - 2025)

Historic Tax Provisions for Neogenomics (NEO) over the last 13 years, with Q3 2025 value amounting to $740000.0.

  • Neogenomics' Tax Provisions rose 59333.33% to $740000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$522000.0, marking a year-over-year increase of 7520.19%. This contributed to the annual value of -$1.9 million for FY2024, which is 7865.05% up from last year.
  • According to the latest figures from Q3 2025, Neogenomics' Tax Provisions is $740000.0, which was up 59333.33% from -$724000.0 recorded in Q2 2025.
  • Over the past 5 years, Neogenomics' Tax Provisions peaked at $976000.0 during Q1 2021, and registered a low of -$5.7 million during Q2 2022.
  • Its 5-year average for Tax Provisions is -$1.7 million, with a median of -$2.3 million in 2023.
  • In the last 5 years, Neogenomics' Tax Provisions tumbled by 74238.81% in 2021 and then surged by 59333.33% in 2025.
  • Over the past 5 years, Neogenomics' Tax Provisions (Quarter) stood at -$2.4 million in 2021, then fell by 16.03% to -$2.8 million in 2022, then skyrocketed by 66.16% to -$960000.0 in 2023, then increased by 16.25% to -$804000.0 in 2024, then surged by 192.04% to $740000.0 in 2025.
  • Its last three reported values are $740000.0 in Q3 2025, -$724000.0 for Q2 2025, and $266000.0 during Q1 2025.